NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
July 25, 2006 • Volume 3 / Number 30 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

The information and links on this page are no longer being updated and are provided for reference purposes only.

Funding OpportunitiesFunding Opportunities

Featured Meetings and Events
A calendar of scientific meetings and events sponsored by the National Institutes of Health (NIH) is available at http://calendar.nih.gov.
Following are newly released NCI research funding opportunities:

Mechanisms of Immune Modulation
Announcement Number: RFA-AT-06-005
Application Receipt Date: Dec. 12, 2006

This funding opportunity will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3507. Inquiries: Dr. Young S. Kim - yk47s@nih.gov

Assay Development for High Throughput Molecular Screening
Announcement Number: RFA-RM-07-001
Letter of Intent Receipt Date: Sept. 8, 2006
Application Receipt Date: Sept. 22, 2006

This is a renewal of RFA-RM-06-004 and will use the R21 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3508. Inquiries: Dr. Mark Scheideler - scheidelerm@ninds.nih.gov

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.